The Scientific and Research Team at Freeline Therapeutics leads the discovery, development, and optimization of innovative AAV-based gene therapies. This team conducts cutting-edge research to identify therapeutic targets, designs preclinical studies, and drives project management to advance gene therapy candidates from concept to clinical trials, aiming to transform the lives of patients with inherited systemic debilitating diseases.
View all